And thinking about the metabolic side of things, is GLP-1s like Monjaro and Ozempic, are they part of the protocol? Well, one

of the crucial things is because women with polycystic ovary syndrome have that metabolic imbalance, They are more prone to having weight problems with obesity.

And they also struggle to lose weight.

And we know that weight gain in polycystic ovarian syndrome, or PMOS, makes it worse.

So it becomes this vicious cycle.

And we know that losing weight can improve fertility.

It can improve the skin.

And has there been any particularly memorable moments in the lab or during your experiments over the years, at least ones that could be shared with the general